A new type of MRI scan may distinguish active from chronic MS lesions without the need for injected contrast dye.

New multiplexed imaging technology using standard clinical MRI systems can simultaneously map more than 20 biomarkers in high resolution, providing a comprehensive view of the brain with a single scan ...

New multiplexed imaging technology using standard clinical MRI systems can simultaneously map more than 20 biomarkers in high resolution, providing a comprehensive view of the brain with a single scan ...

The first participant has been dosed in an investigator-led Phase 2 trial testing pegsebrenatide as a potential treatment for ...

"I don't want my MS to win," she said. "You just have to be strong and resilient because it can pull you down a plug hole and ...

Scott McPhillimy thought wife Suzanne would have to care for him after his MS diagnosis - until tragedy struck in 2020.

Interim results from the first three brain cancer patients treated; two of whom demonstrated complete response, with total disappearance of all ...

The Multiple Sclerosis Association of America (MSAA) is proud to announce our 12th Improving Lives Benefit, in support of the multiple sclerosis community, on Thursday, May 7, 2026, at 6:00 PM ET at ...

Neuraly, Inc., a wholly owned subsidiary of D&D Pharmatech, Inc. (KOSDAQ: 347850), announced that the first patient has been dosed in a Phase 2 Investigator-Initiated Trial (IIT) evaluating ...

Liz Rudisill put off going to the doctor for years, but once she did, she pushed for her care. Diagnosed with meningioma that ...

Scott McPhillimy, 37, from East Kilbride, Scotland, United Kingdom, says his multiple sclerosis has not progressed after ...